col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


95 Ergebisse       Seite 1

 [1] 
Oxford University Press: Clinical Chemistry
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Okt―02 B-152 Analysis of carbonyl compounds in exhaled breath for detection of COVID-19 X Fu, Z Xie, J D Morris, A D Alksas, A D El-Baz, J D Huang, M H Nantz
2 [GO] 2024―Okt―02 B-352 Effects of COVID-19 on Breast Cancer Positivity: A Retrospective and Predictive Study S S de Andrade, G Moreno Rodrigues de Souza, H Pagan Cilotti, D Ribeiro Ramadan-Boscolo, S Tufik
3 [GO] 2024―Okt―02 A-288 Active Surveillance Cultures: Frequency of Microorganisms and Phenotypic Resistance Profile From Brazilian Public Hospitals After COVID-19 Pandemic Peak S S de Andrade, J M Nurmberger, F M Inoue, A P Lobo, D R Ramadan-Boscolo, S Tufik
4 [GO] 2024―Okt―02 B-136 From Result to Response: The Development of Laboratory-Based Scoring Models to Predict COVID-19 Patient Outcomes M S Scott, O Vishnyakova, L Elliot, G Morgan, S Casalino, E Frangione, et al. (+17)
5 [GO] 2024―Okt―02 A-240 Validation of the OSOM Flu SARS-CoV-2 Combo Home Test S Yaji, K Shimizu, D Fong, E Gonzalez, T Aihara, N Delgado Flores, et al. (+8)
6 [GO] 2024―Okt―02 B-050 A comparison of two semi-quantitative tests, Abbott’s Advise DX SARS-CoV-2 IgG II and Beckman Coulter’s Access SARS-COV-2 IgG II, for measuring IgG antibody levels after Sars-CoV-2 Pfizer-BioNTech vaccination W Niklinski, E Niklinska, S Siddiqui, D Ferrer Peace
7 [GO] 2024―Okt―02 A-019 Unexpectedly High Cardiac Troponin Values in Healthy Athletes after SARS-CoV-2 Infection A Hammerer-Lercher, C Kissel, S Wittfooth, G Huré, A Sanzone, P Neyer, et al. (+6)
8 [GO] 2024―Okt―02 A-235 Systemic Inflammation is associated with worse outcomes from SARS-CoV-2 infection but not neutralizing antibody C Farnsworth, L Jackson, B Roemmich, D Daghfal, G Murtagh, E Frias, et al. (+4)
9 [GO] 2024―Okt―02 B-087 Sars-cov-2 Nt Chip test performance: a novel microarray-based enzymatic immunoassay for in vitro identification of neutralizing antibodies against emerging variants J Levi, J F de Souza, V Vidotto Frade, A F Justino Feo, G Laginestra Francisco, D Rodrigues de Sousa, et al. (+4)
10 [GO] 2024―Okt―02 A-233 Wastewater-based surveillance for SARS-CoV-2 Subvariants using the Nanopore Sequencing in South Korea Y Kim, T Noh, S Lee, Y Kim, K Lee
11 [GO] 2024―Okt―02 B-086 Evaluation of Long-Term Adaptive Immune Responses Specific to SARS-CoV-2: Effect of Various Vaccination and Omicron Exposure E Oh, H Kang, J Jung, J Lee, G Ko, H Park, A Choi
12 [GO] 2024―Okt―02 B-026 Transforming PCR protocols in pandemic response with automated non-contact liquid dispensing L Henry, F Pitt, S Mulla, T Redgwell, D Grovewood, R Buckley-Taylor, et al. (+5)
13 [GO] 2024―Okt―02 A-287 Mycoplasma pneumoniae outbreak in 2023: Post pandemic resurgence of an atypical bacterial pathogen V Singh, P Upadhyay
14 [GO] 2024―Jul―16 Is Long COVID a Complement Dysregulation Disease? Wioleta M Zelek
15 [GO] 2023―Dez―01 Clinical Assessment of SARS-CoV-2 Antibodies in Oral Fluids Following Infection and Vaccination Christopher D Heaney, Heidi Hempel, Kate L DeRosa, Ligia A Pinto, Nicholas J Mantis
16 [GO] 2023―Sep―27 A-294 Duplicate Testing of Samples Suspected of SARS-CoV-2 Infection Could Prevent Misdiagnosis of Covid-19 J Sánchez-Sánchez, G Thapa, A Mylona, R Vuono
17 [GO] 2023―Sep―27 A-249 Theranostic Algorithm: sensitivity and Specificity of a Composite Index Test for Guiding Treatment in Severe COVID-19 N V De Vos, M Bruyneel, C Duterme, A Roman, H Dahma, S Alard, et al. (+4)
18 [GO] 2023―Sep―27 A-372 Increased Sensitivity in Detection of SARS-CoV-2 Antigen Using RADI COVID-19 Ag Rapid Test S Kee, J Choi, J Jeon, M Heo, J Park, H Choi
19 [GO] 2023―Sep―27 B-147 Evaluation of Laboratory Database: Is there a Causal Relationship between COVID-19 and Type 1 Diabetes M C Castelo, M Cruz, S P Bandeira, A C Lopes, L L Cavalcante
20 [GO] 2023―Sep―27 A-378 Clinical Evaluation and Implementation of Rapid COVID-19 Antigen Test in Qatar J S Said, F Afreen, D Al-Wali, E A Al Kuwari, Z M Kabir, A M Salem
21 [GO] 2023―Sep―27 A-231 Prediction of Severe COVID-19 Based on Routine Biomarker Assessment H Kapoor, C Bi, A E Salm, J Szymanski, Y D Goldstein, L R Wolgast, et al. (+3)
22 [GO] 2023―Sep―27 A-336 Comparison Between the Immune Profile of Pregnant and Postpartum Women with and without COVID-19 by Flow Cytometry M L Machado, A T de Souza, S E Silva, A L Fonseca, J D Camargo, A J Vale, et al. (+6)
23 [GO] 2023―Sep―27 A-229 Immune Biomarkers Associated with COVID-19 Disease Severity in an Urban, Hospitalized Population A B Chambliss, M Aljehani, B Tran, X Chen, E Elton, C Garri, et al. (+3)
24 [GO] 2023―Sep―27 A-123 Increased Rate of Recurrent Hemolysis Is Associated With COVID-19 Infection and Propofol Administration in the Intensive Care Unit (ICU) R Fyffe-Freil, A A Wockenfus, E A Hain, M A Nicklas, N A Baumann, B M Katzman
25 [GO] 2023―Sep―27 A-087 Relationship among Different Inflammatory Markers in Patients with COVID-19 Infections R Yadav, P Chopra, T Sehgal, S K Datta, A Ningombam, A Ahirwar
26 [GO] 2023―Sep―27 A-136 Usefulness of Presepsin and Thrombomodulin Measurements for Predicting COVID-19 Mortality A Yamazaki, Y Nukui, T Kameda, R Saito, Y Koda, N Ichimura, et al. (+2)
27 [GO] 2023―Sep―27 A-175 Objective Indexes for Comparing Platelet Usage Among Peer Hospitals During the COVID-19 Pandemic Y Tu, Y Hsueh, Y Cheng, T Lin, T Chiueh
28 [GO] 2023―Sep―27 A-292 The Use of Third-Party Controls During Covid-19 Pandemic: An Alternative to the Lack of Other Respiratory Infections J Sánchez-Sánchez
29 [GO] 2023―Sep―27 B-046 Curious Thing, an Artificial Intelligence (AI) Based Conversational Agents in COVID-19 Patient Management J S Chow
30 [GO] 2023―Sep―27 A-289 Emergence of Unusual Non-Fermentative Gram-Negative Bacilli Associated to COVID-19 Period at Brazilian Hospitals J M Nurmberger, F M Inoue, A T Lobo, D R Ramadan, S Tufik
31 [GO] 2023―Sep―27 B-045 A Descriptive Study of the Clinical Impacts on COVID-19 Survivors Using Telemonitoring (The TeleCOVID Study) J S Chow
32 [GO] 2023―Sep―27 A-275 Clinical Evaluation of SMARTCHEK® SARS-CoV-2 Detection Kit and SMARTCHEK® SARS-CoV-2 Fast Detection Kit for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nasopharyngeal Swabs J Ahn, W Lee, S Yoon, S Cho
33 [GO] 2023―Sep―27 A-276 Clinical Performance Evaluation of SMARTCHEK® SARS-CoV-2 Detection Kit and SMARTCHEK® SARS-CoV-2 Fast Detection Kit for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Saliva S Park, J Yoo, S Cho
34 [GO] 2023―Sep―27 B-013 Association Between Laboratory Parameters Analysis and Clinical Severity in Patients With Coronavirus Disease (Covid 19) at Hospital Universitario Fundación Santa Fe O Martinez Nieto, H A Gonzalez, C E Saavedra Andrade, D M Bertel Rodriguez, P A Rodriguez Urrego, J P Vargas Gallo
35 [GO] 2023―Sep―27 A-259 Detecting Human RNase P Gene Prevents False-Negative of SARS-CoV-2 F Chuang
36 [GO] 2023―Sep―27 B-085 Sars-cov-2 nt-chip: A Multiplex eia Platform for Detect Humoral Response and Neutralizing Antibodies Against Sars-cov-2 J R Siqueira, M L Moreira, E M Carvalho, F Moruzzi, D D Luche, M Kintrup
37 [GO] 2023―Sep―27 A-347 Performance Evaluation of Standard Q COVID/FLU Ag Combo for Detection of SARS-CoV-2 and Influenza A and B Antigens from the Patients with Suspected Respiratory Infections S Kim, W Choi
38 [GO] 2023―Sep―27 B-158 Application of Statistical Analysis as a Tool to Monitor the Variation of SARS-CoV-2 and Other Respiratory Viruses G C Carvalho, J M Nurmberger, B B Perez, D R Ramadan, S Tufik
39 [GO] 2023―Sep―27 A-265 Disparities Among SARS-CoV-2 Antibody Positivity in Healthcare Workers K E Mullins, R Christenson
40 [GO] 2023―Sep―27 B-077 Comparison of SARS-CoV-2 Antibody Profile and Omicron-Specific Neutralizing Activity Before and After mRNA Booster Vaccines: Bivalent vs. Original Formulation A Windau, J Meyers, X Yang, R Pontoni, C Schmotzer, J Noguez, et al. (+2)
41 [GO] 2023―Sep―27 A-235 Results and Interpretation: Serology Testing Platforms and Assays Compatibility Assessment for MASTM SARS-CoV-2 IgG Quality Controls H Wang, N Krishnaswami, D Crandall, R Hu
42 [GO] 2023―Sep―27 B-108 T-cell-mediated Immunity against SARS-CoV-2 in Health Care Workers: Head-to-head Comparison of Two Interferon-Gamma Release Assays and Associations between Cellular and Humoral Immunity M Sabalza, J Martinek, H Tomášková, A Lochmanová, H Zelená, J Motlochová, et al. (+7)
43 [GO] 2023―Sep―27 B-251 Nmr Lipoproteins Help to Reveal Subphenotypes of Phenoreversion from sars-cov-2 Infection J Wist, S Lodge, R Masuda, P Nitschke, C Cannet, H Schaefer, et al. (+5)
44 [GO] 2023―Sep―27 A-022 Muscle and Cardiac Marker Levels Impact for SARS-CoV-2 Infection G C Carvalho, R P Carvalho, D R Ramadan, S Tufik
45 [GO] 2023―Sep―27 A-252 Differentiation of SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus Using a Single Swab: A Clinical Performance Evaluation of the BD MAX System Multiplex PCR Assay M Faron, N Ledeboer, B Van Der Pol, T Davis, E Lockamy, S Paradis, J Andrews
46 [GO] 2023―Sep―27 A-282 Coinfection Rates of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus G W Pratt, M Platt, C Wong, L V Rao
47 [GO] 2023―Sep―27 B-091 Assessing Postvaccination SARS-CoV-2 Neutralizing Antibodies at Different Timepoints: a Laboratory-Based Study G M Souza, G C Carvalho, R A Nunes, F M Cristaldi, D R Ramadan, S Tufik
48 [GO] 2023―Sep―27 B-089 Development of a Secondary Standard for Quantitation of IgG Antibodies to SARS-CoV-2 Proteins in a Multiplex Assay N Venkateswaran, J Sarwar, W M Nelson, K S Venkateswaran
49 [GO] 2023―Sep―27 B-230 Monitoring SARS-CoV-2 Subvariants for Evaluation of the Diagnostic Kit’s Annealing Site Using Nanopore Sequencing Y Kim, T Noh, S Lee, Y Kim, D Prakash, K Lee
50 [GO] 2023―Sep―27 A-278 Development and Validation of Platform Independent, Turbidimetric Sars-CoV-2 Total Antibody Assay M Jaquemar, T Nilsen, A Safdari, A Haukebø, E Trosten, A Havelka, Ø Olsvik
51 [GO] 2023―Sep―27 A-307 Spread Dynamic of SARS-CoV-2 Variants and Related Alterations in Transmission Rates: A National Scale Study J D Silva, A B de Lima, L B Alvim, F S Malta, C P Mendonça, P L Fonseca, et al. (+3)
52 [GO] 2023―Sep―27 A-086 Vitamin D and its Variation in a Pandemic Context: Pre-pandemic-Intra-pandemic-Post-pandemic Analysis in the Province of Buenos Aires - Argentina P N Canala, M D Canala, M Spiccia, G Ghioni
53 [GO] 2023―Mai―10 Correction to: Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection
54 [GO] 2022―Jul―27 Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection Anda Bularga, Ellen Oskoui, Takeshi Fujisawa, Sara Jenks, Rachel Sutherland, Fred S Apple, et al. (+2)
55 [GO] 2022―Jul―27 Commentary on Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection Peter A Kavsak
56 [GO] 2022―Jul―27 Commentary on Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection Bernard Croal
57 [GO] 2022―Jun―07 PCR-Based Screening Tests for SARS-CoV-2 Mutations: What Is the Best Way to Identify Variants? Akira Aoki, Yoko Mori, Yoshinori Okamoto, Hideto Jinno
58 [GO] 2021―Dez―05 Subclinical myocardial injury and risk of COVID-19 in the general population: The Trøndelag Health Study Magnus Nakrem Lyngbakken, Kristian Hveem, Helge Røsjø, Torbjørn Omland
59 [GO] 2021―Okt―19 Save the COVID-19 point of care nucleic acid test swab after testing to identify variants of concern Byron M Berenger, William Stokes, Leeann Turnbull, Kanti Pabbaraju, Nathan Zelyas, Allison A Venner, Graham A Tipples
60 [GO] 2021―Okt―05 COVID-19 Testing and a Path out of the Pandemic Gigi Gronvall
61 [GO] 2021―Aug―10 Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking Hui Chen, Zhao Li, Sheng Feng, Melissa Richard-Greenblatt, Emily Hutson, Stefen Andrianus, et al. (+19)
62 [GO] 2021―Aug―05 Poor Humoral Response in Solid Organ Transplant Recipients following Complete mRNA SARS-CoV-2 Vaccination Jing Cao, Xiaohui Liu, Alagarraju Muthukumar, Jeffrey Gagan, Patricia Jones, Youli Zu
63 [GO] 2021―Aug―04 Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection Yu Zhang, Chui Mei Ong, Cassandra Yun, Weike Mo, Jeffery D Whitman, Kara L Lynch, Alan H B Wu
64 [GO] 2021―Jul―28 Wide Variation in Cycle Threshold Values Cloud the Interpretation of COVID-19 Infectiousness William Stokes, Jamil Kanji, Jia Hu, Nathan Zelyas, Byron M Berenger
65 [GO] 2021―Jun―09 Mechanisms of myocardial injury in COVID-19 Anda Bularga, Andrew R Chapman, Nicholas L Mills
66 [GO] 2021―Apr―28 TOP-Plus is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability Sabrina E Racine-Brzostek, Mohsen Karbaschi, Christian Gaebler, P J Klasse, Jim Yee, Marina Caskey, et al. (+10)
67 [GO] 2021―Jan―04 Evaluation of high-throughput SARS-CoV-2 serological assays in a longitudinal cohort of patients with mild COVID-19: clinical sensitivity, specificity and association with virus neutralization test Antonin Bal, Bruno Pozzetto, Mary-Anne Trabaud, Vanessa Escuret, Muriel Rabilloud, Carole Langlois-Jacques, et al. (+13)
68 [GO] 2020―Dez―16 Assessment of multiplex digital droplet RT-PCR as a diagnostic tool for SARS-CoV-2 detection in nasopharyngeal swabs and saliva samples Kévin Cassinari, Elodie Alessandri-Gradt, Pascal Chambon, Françoise Charbonnier, Ségolène Gracias, Ludivine Beaussire, et al. (+7)
69 [GO] 2020―Dez―12 Implementation of Reverse Transcriptase Polymerase Chain Reaction Testing for Severe Acute Respiratory Syndrome Coronavirus-2 Under the U.S. Food and Drug Administration Emergency Use Authorization Joel A Lefferts, Samantha F Allen, Heather B Steinmetz, Gregory J Tsongalis
70 [GO] 2020―Dez―01 Corrigendum to SARS-CoV-2 Serology: Much Hype, Little Data
71 [GO] 2020―Nov―04 DNA cross-reactivity of the CDC-specified SARS-COV-2 specimen control leads to potential for false negatives and underreporting of viral infection Adam P Rosebrock
72 [GO] 2020―Okt―10 Cardiac Troponin Testing in Patients with COVID-19: A Strategy for Testing and Reporting Results Peter A Kavsak, Ola Hammarsten, Andrew Worster, Stephen W Smith, Fred S Apple
73 [GO] 2020―Okt―10 Deus ex machina? Predicting SARS-CoV-2 Infection from Lab Tests Using Machine Learning Christopher R McCudden
74 [GO] 2020―Sep―18 Mass Spectrometry for COVID-19 Jeffrey A SoRelle, Khushbu Patel, Laura Filkins, Jason Y Park
75 [GO] 2020―Sep―04 Cautionary note on contamination of reagents used for molecular detection of SARS-CoV-2 Jim F Huggett, Vladimir Benes, Stephen A Bustin, Jeremy A Garson, Karthyn Harris, Martin Kammel, et al. (+11)
76 [GO] 2020―Sep―04 Evaluation of Orthogonal Testing Algorithm for Detection of SARS-CoV-2 IgG Antibodies Gang Xu, Anthony J Emanuel, Satish Nadig, Shikhar Mehrotra, Brittany A Caddell, Scott R Curry, et al. (+2)
77 [GO] 2020―Aug―19 Routine laboratory blood tests predict SARS-CoV-2 infection using machine learning He S Yang, Yu Hou, Ljiljana V Vasovic, Peter Steel, Amy Chadburn, Sabrina E Racine-Brzostek, et al. (+6)
78 [GO] 2020―Aug―07 Side by side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity Thomas Perkmann, Nicole Perkmann-Nagele, Marie-Kathrin Breyer, Robab Breyer-Kohansal, Otto C Burghuber, Sylvia Hartl, et al. (+9)
79 [GO] 2020―Jul―24 SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission Divinlal Harilal, Sathishkumar Ramaswamy, Tom Loney, Hanan Al Suwaidi, Hamda Khansaheb, Abdulmajeed Alkhaja, et al. (+5)
80 [GO] 2020―Jul―20 The cause of Severe Acute Respiratory Syndrome: What did we learn from it? Malik Peiris, Leo L M Poon
81 [GO] 2020―Mai―30 Clinical Performance of the Roche SARS-CoV-2 Serologic Assay Mei San Tang, Karl G Hock, Nicole M Logsdon, Jennifer E Hayes, Ann M Gronowski, Neil W Anderson, Christopher W Farnsworth
82 [GO] 2020―Mai―30 Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies Julien Favresse, Christine Eucher, Marc Elsen, Tré-Hardy Marie, Jean-Michel Dogné, Jonathan Douxfils
83 [GO] 2020―Mai―20 Molecular and serological assays for SARS-CoV-2: insights from genome and clinical characteristics Jiping Shi, Dongsheng Han, Runling Zhang, Jinming Li, Rui Zhang
84 [GO] 2020―Mai―12 Clinical Performance of Two SARS-CoV-2 Serologic Assays Mei San Tang, Karl G Hock, Nicole M Logsdon, Jennifer E Hayes, Ann M Gronowski, Neil W Anderson, Christopher W Farnsworth
85 [GO] 2020―Mai―06 Rapid detection of SARS-CoV-2 by low volume real-time single tube reverse transcription recombinase polymerase amplification using an exo probe with an internally linked quencher (exo-IQ) Ole Behrmann, Iris Bachmann, Martin Spiegel, Marina Schramm, Ahmed Abd El Wahed, Gerhard Dobler, et al. (+2)
86 [GO] 2020―Mai―04 Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization Vikas Peddu, Ryan C Shean, Hong Xie, Lasata Shrestha, Garrett A Perchetti, Samuel S Minot, et al. (+8)
87 [GO] 2020―Apr―29 Modeling SARS-CoV-2 positivity using laboratory data: timing is everything Thor Larson, Karissa Culbreath, Dennis Chavez, Richard Larson, Michael Crossey, David G Grenache
88 [GO] 2020―Apr―28 SARS-CoV-2 Serology: Much Hype, Little Data Christopher W Farnsworth, Neil W Anderson
89 [GO] 2020―Apr―17 Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform Lin Yu, Shanshan Wu, Xiaowen Hao, Xue Dong, Lingling Mao, Vicent Pelechano, et al. (+2)
90 [GO] 2020―Apr―11 Limits of Detection of Six Approved RT-PCR Kits for the Novel SARS-coronavirus-2 (SARS-CoV-2) Xueliang Wang, Hangping Yao, Xing Xu, Pengyin Zhang, Minmin Zhang, Junbin Shao, et al. (+2)
91 [GO] 2020―Apr―02 Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads Yang Pan, Luyao Long, Daitao Zhang, Tingting Yan, Shujuan Cui, Peng Yang, et al. (+2)
92 [GO] 2020―Mrz―09 The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception Ping Wang, Neil Anderson, Yang Pan, Leo Poon, Carmen Charlton, Nathan Zelyas, et al. (+3)
93 [GO] 2020―Feb―19 Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak Matthew J Binnicker
94 [GO] 2020―Feb―06 Racing towards the development of diagnostics for a novel coronavirus (2019-nCoV) Y M Dennis Lo, Rossa W K Chiu
95 [GO] 2020―Jan―28 Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia Daniel K W Chu, Yang Pan, Samuel M S Cheng, Kenrie P Y Hui, Pavithra Krishnan, Yingzhi Liu, et al. (+6)
 [1] 

95 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.007 sec